Hennion & Walsh Asset Management’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
154,492
-4,891
| -3% | -$40.2K | 0.05% | 435 |
|
|
2025
Q1 | $1.14M | Sell |
159,383
-5,346
| -3% | -$38.2K | 0.05% | 444 |
|
|
2024
Q4 | $1.27M | Buy |
164,729
+13,014
| +9% | +$101K | 0.06% | 407 |
|
|
2024
Q3 | $1.59M | Buy |
151,715
+17,525
| +13% | +$184K | 0.07% | 341 |
|
|
2024
Q2 | $1.57M | Buy |
134,190
+27,906
| +26% | +$327K | 0.08% | 311 |
|
|
2024
Q1 | $2.24M | Buy |
106,284
+32,584
| +44% | +$687K | 0.12% | 235 |
|
|
2023
Q4 | $1.32M | Buy |
73,700
+13,336
| +22% | +$239K | 0.08% | 339 |
|
|
2023
Q3 | $994K | Sell |
60,364
-5,425
| -8% | -$89.3K | 0.06% | 359 |
|
|
2023
Q2 | $1.32M | Sell |
65,789
-36,474
| -36% | -$729K | 0.08% | 316 |
|
|
2023
Q1 | $1.93M | Sell |
102,263
-3,012
| -3% | -$57K | 0.12% | 211 |
|
|
2022
Q4 | $2.39M | Buy |
105,275
+11,394
| +12% | +$258K | 0.15% | 176 |
|
|
2022
Q3 | $2.48M | Buy |
93,881
+4,387
| +5% | +$116K | 0.16% | 160 |
|
|
2022
Q2 | $2.21M | Buy |
89,494
+21,487
| +32% | +$531K | 0.14% | 186 |
|
|
2022
Q1 | $2.26M | Buy |
68,007
+14,260
| +27% | +$473K | 0.12% | 207 |
|
|
2021
Q4 | $1.76M | Buy |
53,747
+22,859
| +74% | +$748K | 0.09% | 254 |
|
|
2021
Q3 | $1.3M | Buy |
30,888
+10,576
| +52% | +$443K | 0.07% | 303 |
|
|
2021
Q2 | $789K | Buy |
+20,312
| New | +$789K | 0.04% | 417 |
|